secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2024-07-12T23:59:59+00:00
Accession:  0001214659-24-012340
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro announces 1-for-10 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split effective July 16, 2024; reduces outstanding shares from ~7.98M to ~798K.
- Split aims to meet Nasdaq minimum bid price of $1.00 per share.
- No fractional shares; cash payments for fractional shares via Computershare.
- Authorized shares and par value ($0.0001) unchanged.
- Stockholders authorized split range 1:2 to 1:20 in April; board set 1:10 in June.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465924012340/0001214659-24-012340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465924012340/b7112428k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-24-012340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer